156 related articles for article (PubMed ID: 31900198)
1. Estimating dose-response for time to remission with instrumental variable adjustment: the obscuring effects of drug titration in Genome Based Therapeutic Drugs for Depression Trial (GENDEP): clinical trial data.
Hellier J; Emsley R; Pickles A
Trials; 2020 Jan; 21(1):10. PubMed ID: 31900198
[TBL] [Abstract][Full Text] [Related]
2. Early and delayed onset of response to antidepressants in individual trajectories of change during treatment of major depression: a secondary analysis of data from the Genome-Based Therapeutic Drugs for Depression (GENDEP) study.
Uher R; Mors O; Rietschel M; Rajewska-Rager A; Petrovic A; Zobel A; Henigsberg N; Mendlewicz J; Aitchison KJ; Farmer A; McGuffin P
J Clin Psychiatry; 2011 Nov; 72(11):1478-84. PubMed ID: 22127194
[TBL] [Abstract][Full Text] [Related]
3. An inflammatory biomarker as a differential predictor of outcome of depression treatment with escitalopram and nortriptyline.
Uher R; Tansey KE; Dew T; Maier W; Mors O; Hauser J; Dernovsek MZ; Henigsberg N; Souery D; Farmer A; McGuffin P
Am J Psychiatry; 2014 Dec; 171(12):1278-86. PubMed ID: 25017001
[TBL] [Abstract][Full Text] [Related]
4. Depression symptom dimensions as predictors of antidepressant treatment outcome: replicable evidence for interest-activity symptoms.
Uher R; Perlis RH; Henigsberg N; Zobel A; Rietschel M; Mors O; Hauser J; Dernovsek MZ; Souery D; Bajs M; Maier W; Aitchison KJ; Farmer A; McGuffin P
Psychol Med; 2012 May; 42(5):967-80. PubMed ID: 21929846
[TBL] [Abstract][Full Text] [Related]
5. Body weight as a predictor of antidepressant efficacy in the GENDEP project.
Uher R; Mors O; Hauser J; Rietschel M; Maier W; Kozel D; Henigsberg N; Souery D; Placentino A; Perroud N; Dernovsek MZ; Strohmaier J; Larsen ER; Zobel A; Leszczynska-Rodziewicz A; Kalember P; Pedrini L; Linotte S; Gunasinghe C; Aitchison KJ; McGuffin P; Farmer A
J Affect Disord; 2009 Nov; 118(1-3):147-54. PubMed ID: 19269691
[TBL] [Abstract][Full Text] [Related]
6. Patterns and predictors of remission, response and recovery in major depression treated with fluoxetine or nortriptyline.
Joyce PR; Mulder RT; Luty SE; Sullivan PF; McKenzie JM; Abbott RM; Stevens IF
Aust N Z J Psychiatry; 2002 Jun; 36(3):384-91. PubMed ID: 12060188
[TBL] [Abstract][Full Text] [Related]
7. Exploring the role of drug-metabolising enzymes in antidepressant side effects.
Hodgson K; Tansey KE; Uher R; Dernovšek MZ; Mors O; Hauser J; Souery D; Maier W; Henigsberg N; Rietschel M; Placentino A; Craig IW; Aitchison KJ; Farmer AE; Dobson RJ; McGuffin P
Psychopharmacology (Berl); 2015 Jul; 232(14):2609-17. PubMed ID: 25761838
[TBL] [Abstract][Full Text] [Related]
8. Suicidal ideation during treatment of depression with escitalopram and nortriptyline in genome-based therapeutic drugs for depression (GENDEP): a clinical trial.
Perroud N; Uher R; Marusic A; Rietschel M; Mors O; Henigsberg N; Hauser J; Maier W; Souery D; Placentino A; Szczepankiewicz A; Jorgensen L; Strohmaier J; Zobel A; Giovannini C; Elkin A; Gunasinghe C; Gray J; Campbell D; Gupta B; Farmer AE; McGuffin P; Aitchison KJ
BMC Med; 2009 Oct; 7():60. PubMed ID: 19832967
[TBL] [Abstract][Full Text] [Related]
9. Antidepressant drug-specific prediction of depression treatment outcomes from genetic and clinical variables.
Iniesta R; Hodgson K; Stahl D; Malki K; Maier W; Rietschel M; Mors O; Hauser J; Henigsberg N; Dernovsek MZ; Souery D; Dobson R; Aitchison KJ; Farmer A; McGuffin P; Lewis CM; Uher R
Sci Rep; 2018 Apr; 8(1):5530. PubMed ID: 29615645
[TBL] [Abstract][Full Text] [Related]
10. Stressful life events, cognitive symptoms of depression and response to antidepressants in GENDEP.
Keers R; Uher R; Gupta B; Rietschel M; Schulze TG; Hauser J; Skibinska M; Henigsberg N; Kalember P; Maier W; Zobel A; Mors O; Kristensen AS; Kozel D; Giovannini C; Mendlewicz J; Kumar S; McGuffin P; Farmer AE; Aitchison KJ
J Affect Disord; 2010 Dec; 127(1-3):337-42. PubMed ID: 20609482
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide pharmacogenetics of antidepressant response in the GENDEP project.
Uher R; Perroud N; Ng MY; Hauser J; Henigsberg N; Maier W; Mors O; Placentino A; Rietschel M; Souery D; Zagar T; Czerski PM; Jerman B; Larsen ER; Schulze TG; Zobel A; Cohen-Woods S; Pirlo K; Butler AW; Muglia P; Barnes MR; Lathrop M; Farmer A; Breen G; Aitchison KJ; Craig I; Lewis CM; McGuffin P
Am J Psychiatry; 2010 May; 167(5):555-64. PubMed ID: 20360315
[TBL] [Abstract][Full Text] [Related]
12. Melancholic, atypical and anxious depression subtypes and outcome of treatment with escitalopram and nortriptyline.
Uher R; Dernovsek MZ; Mors O; Hauser J; Souery D; Zobel A; Maier W; Henigsberg N; Kalember P; Rietschel M; Placentino A; Mendlewicz J; Aitchison KJ; McGuffin P; Farmer A
J Affect Disord; 2011 Jul; 132(1-2):112-20. PubMed ID: 21411156
[TBL] [Abstract][Full Text] [Related]
13. Absolute Measurements of Macrophage Migration Inhibitory Factor and Interleukin-1-β mRNA Levels Accurately Predict Treatment Response in Depressed Patients.
Cattaneo A; Ferrari C; Uher R; Bocchio-Chiavetto L; Riva MA; ; Pariante CM
Int J Neuropsychopharmacol; 2016 Oct; 19(10):. PubMed ID: 27207917
[TBL] [Abstract][Full Text] [Related]
14. DNA methylation in interleukin-11 predicts clinical response to antidepressants in GENDEP.
Powell TR; Smith RG; Hackinger S; Schalkwyk LC; Uher R; McGuffin P; Mill J; Tansey KE
Transl Psychiatry; 2013 Sep; 3(9):e300. PubMed ID: 24002086
[TBL] [Abstract][Full Text] [Related]
15. Non-random dropout and the relative efficacy of escitalopram and nortriptyline in treating major depressive disorder.
Power RA; Muthén B; Henigsberg N; Mors O; Placentino A; Mendlewicz J; Maier W; McGuffin P; Lewis CM; Uher R
J Psychiatr Res; 2012 Oct; 46(10):1333-8. PubMed ID: 22770672
[TBL] [Abstract][Full Text] [Related]
16. Nortriptyline for the treatment of depression in progressive supranuclear palsy.
Tamai S; Almeida OP
J Am Geriatr Soc; 1997 Aug; 45(8):1033-4. PubMed ID: 9256865
[No Abstract] [Full Text] [Related]
17. Combining clinical variables to optimize prediction of antidepressant treatment outcomes.
Iniesta R; Malki K; Maier W; Rietschel M; Mors O; Hauser J; Henigsberg N; Dernovsek MZ; Souery D; Stahl D; Dobson R; Aitchison KJ; Farmer A; Lewis CM; McGuffin P; Uher R
J Psychiatr Res; 2016 Jul; 78():94-102. PubMed ID: 27089522
[TBL] [Abstract][Full Text] [Related]
18. Antidepressant effects of nortriptyline and escitalopram in the GENDEP study: is one better than the other?
Uher R; Mors O; McGuffin P
Acta Psychiatr Scand; 2013 Apr; 127(4):330. PubMed ID: 23480387
[No Abstract] [Full Text] [Related]
19. Differential efficacy of escitalopram and nortriptyline on dimensional measures of depression.
Uher R; Maier W; Hauser J; Marusic A; Schmael C; Mors O; Henigsberg N; Souery D; Placentino A; Rietschel M; Zobel A; Dmitrzak-Weglarz M; Petrovic A; Jorgensen L; Kalember P; Giovannini C; Barreto M; Elkin A; Landau S; Farmer A; Aitchison KJ; McGuffin P
Br J Psychiatry; 2009 Mar; 194(3):252-9. PubMed ID: 19252156
[TBL] [Abstract][Full Text] [Related]
20. A new role for nortriptyline in depression associated with vascular disease?
Kunte H; Rentzsch J; Kronenberg G
Am J Psychiatry; 2015 Feb; 172(2):201. PubMed ID: 25640936
[No Abstract] [Full Text] [Related]
[Next] [New Search]
